SBBP Insider Trading Activity and SEC Form 4 Filings
SBBP insider trading summary
No open-market insider purchases or sales of Strongbridge Biopharma plc (SBBP) have been reported on SEC Form 4 in the past 12 months.
Latest SBBP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 24, 2020 | David N Gill | Director | Buy | $17K (8,000 @ $2.13) |
| Sep 18, 2020 | Caxton Corp | 10% Owner | Buy | $13K (6,000 @ $2.20) |
| Sep 18, 2020 | Cdk Associates, L.L.C. | 10% Owner | Buy | $13K (6,000 @ $2.20) |
| Sep 18, 2020 | Bruce Kovner | 10% Owner | Buy | $13K (6,000 @ $2.20) |
| Sep 17, 2020 | Bruce Kovner | 10% Owner | Buy | $3.3M (1,473,377 @ $2.25) |
| Sep 17, 2020 | Cdk Associates, L.L.C. | 10% Owner | Buy | $3.3M (1,473,377 @ $2.25) |
| Sep 17, 2020 | Caxton Corp | 10% Owner | Buy | $3.3M (1,473,377 @ $2.25) |
| Dec 27, 2018 | Cdk Associates, L.L.C. | 10% Owner | Buy | $72K (18,200 @ $3.98) |
| Dec 27, 2018 | Caxton Corp | 10% Owner | Buy | $72K (18,200 @ $3.98) |
| Dec 27, 2018 | Bruce Kovner | 10% Owner | Buy | $72K (18,200 @ $3.98) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.